Lockheed Martin has continued its slide this week, closing at $512.21 on September 29, down another 1.9% on the week and now off 9.2% over the past month, widening the gap to analyst targets further still.
The sector provided no shelter. RTX lost 2.1% on the week, GD dropped 3.2%, and HII and HO each fell more than 4%. NOC fared best among the large primes, slipping just 1%. Within that peer group, Lockheed's relative performance was roughly middle of the road, but the direction of travel across the defense cohort is uniformly down. The stock now carries almost none of the 13% post-Q2 gain it notched on July 23, that entire rally has effectively been unwound with three weeks left before the Q3 print on October 20.
Short positioning is not the driver of this move, and it has not become one over the course of the decline. Short interest amounts to just over 1% of the free float, down about 11% from where it was a month ago, and the borrow market is as relaxed as it gets. The cost to borrow has eased to 0.36%, off 14% on the week and 22% over the past month. Availability is extraordinarily loose at roughly 7,500%, meaning there are scores of shares available to borrow for every share currently lent out. This is not a stock under pressure from shorts building positions into a binary event. The ORTEX short score of 30 sits at its lowest reading of the past two weeks, consistent with a market that sees no compelling reason to press the short side here. Options positioning is similarly unremarkable: the put/call ratio of 0.82 is barely half a standard deviation above its 20-day average of 0.81, well inside the year's range of 0.47 to 1.04. Taken together, the lending and options data describe a stock that is simply drifting lower on long selling, not one being actively targeted.
The Street remains conspicuously more optimistic than the market. The mean analyst price target of $636.74 implies roughly 24% upside from current levels, a gap that has widened noticeably as the stock has fallen. The most recent structural shift in analyst opinion was UBS upgrading to Buy on September 8, raising its target to $674, the only rating change in the past three months. Most other coverage is anchored at Hold or equivalent: Morgan Stanley holds Equal-Weight at $690, RBC at Sector Perform with a $600 target, and TD Cowen at Hold with $560. The bull case centers on strong free cash flow, the Q4 2025 pre-funding of pension obligations boosting near-term FCF guidance, and the prospect of an upward re-rating as defense budget visibility improves. The bear case points to the loss of the NGAD next-generation fighter program, persistent uncertainty around the F-35's long-term trajectory, and the risk that any federal budget consolidation squeezes procurement. The EV/EBITDA multiple has compressed to 11.6 times, down from higher levels over the past month, while the PE of 15.9 times has shed about 1.6 turns over 30 days. The analyst recommendation score ranks in the 94th percentile relative to the universe, indicating the Street as a whole is more constructive on LMT than almost any other name, but the consensus rating itself remains a Hold, not a Buy.
Institutional ownership data shows the index and passive managers sitting still, with State Street holding 14.3% and BlackRock 8.2%, their most recent filings both dated August 31. The more active move came from T. Rowe Price, which added 1.36 million shares in the period ending September 1, taking its stake to 1.67 million shares. That is a material addition, though the timing means it was executed at prices above where the stock trades today. Insider activity over the past 90 days has been modestly negative on net, with director John Donovan filing a series of sales in mid-August totaling roughly 3,400 shares across multiple transactions, none of which carried a 10b5-1 plan designation. Retail attention has picked up: the Wikipedia views signal carries a z-score of 1.45 against the company's own 90-day history, the highest recent reading, though this dataset has not been measured to lead reported financial figures and is best read as an attention indicator rather than a fundamental one.
Q3 earnings on October 20 are now the organizing event. After the last two prints, LMT moved sharply: the most recent Q2 release produced a 13.3% gain on the day and an 11.6% gain over the following five sessions, while the Q1 result generated a smaller 0.9% day-one move but an eventual 14.1% five-day gain. Whether the stock enters October 20 having stabilized or extended its slide, the earnings reaction history suggests the market treats each print as a meaningful reset, and the widening gap between current prices and consensus targets means the setup heading into that date will be worth monitoring closely.
See the live data behind this article on ORTEX.
Open LMT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
